Indivior Pharmaceuticals (INDV) Total Non-Current Liabilities (2021 - 2026)
Indivior Pharmaceuticals (INDV) recorded Total Non-Current Liabilities of $1.4 billion in Q2 2026, down 0.8% from $1.41 billion a year earlier but up 7.6% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Indivior Pharmaceuticals reported Total Non-Current Liabilities of $1.25 billion, down 3.2% from FY2024.
- Annual Total Non-Current Liabilities has a four-year compound annual growth rate of 10.9% (FY2021 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $1.29 billion in FY2024 (+98.5%), $649 million in FY2023 (-7.2%), $699 million in FY2022 (-15.3%) and $825 million in FY2021.
- Quarterly Total Non-Current Liabilities has ranged from $649 million in Q4 2023 to $1.41 billion in Q2 2025 over the past five years.
- On a year-over-year basis, Total Non-Current Liabilities has declined for three consecutive quarters, with growth averaging 22.5% over the last four quarters.
- Per Business Quant, the preceding three quarters came in at $1.3 billion (Q1 2026), $1.25 billion (Q4 2025) and $1.32 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Indivior Pharmaceuticals | 4.13 Bn | 3.10 Bn | 294.00 Mn | 1.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.23 Bn |
| Sep 30, 2025 | 1.29 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.35 Bn |
| Dec 31, 2024 | 1.27 Bn |
| Dec 31, 2023 | 649.00 Mn |
| Dec 31, 2022 | 699.00 Mn |
| Dec 31, 2021 | 825.00 Mn |
API Access
Indivior Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();